December 15, 2008
SDI and MedImmune Publish Ground-Breaking Study on Geographically Specific, Seasonal RSV Disease Outbreak Data
December 04, 2008
MedImmune Advances Asthma Program with Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
November 28, 2008
MedImmune Receives FDA Complete Response Letter on Motavizumab


